Brown Advisory Inc Spring Works Therapeutics, Inc. Transaction History

Brown Advisory Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$18.36 - $60.07 $10,501 - $34,360	572 Added 10.66%	5,937 $367,000
Q1 2022 Sep 13, 2022	SELL	$48.97 - $65.46 $28,010 - $37,443	-572 Reduced 9.63%	5,365 $303,000
Q1 2022 May 09, 2022	BUY	$48.97 - $65.46 $1,713 - $2,291	35 Added 0.59%	5,937 $368,000
Q4 2021 Jan 27, 2022	BUY	$53.3 - $75.84 $314,576 - $447,607	5,902 New	5,902 $366,000

220

66.8M

64.7K

150K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $1.87B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.